Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Concomitant radiotherapy and transarterial chemoembolization reduce skeletal-related events related to bone metastases from renal cell carcinoma.

Heianna J, Makino W, Ariga T, Ishikawa K, Kusada T, Maemoto H, Toguchi M, Ito J, Goya M, Miyazato M, Iraha Y, Murayama S.

Eur Radiol. 2019 Nov 14. doi: 10.1007/s00330-019-06454-8. [Epub ahead of print]

PMID:
31728686
2.

Unveiling Two Consecutive Hydroxylations: Mechanisms of Aromatic Hydroxylations Catalyzed by Flavin-Dependent Monooxygenases for the Biosynthesis of Actinorhodin and Related Antibiotics.

Hashimoto M, Taguchi T, Ishikawa K, Mori R, Hotta A, Watari S, Katakawa K, Kumamoto T, Okamoto S, Ichinose K.

Chembiochem. 2019 Sep 18. doi: 10.1002/cbic.201900490. [Epub ahead of print]

PMID:
31532569
3.

Multi-institutional evaluation of knowledge-based planning performance of volumetric modulated arc therapy (VMAT) for head and neck cancer.

Kamima T, Ueda Y, Fukunaga JI, Shimizu Y, Tamura M, Ishikawa K, Monzen H.

Phys Med. 2019 Aug;64:174-181. doi: 10.1016/j.ejmp.2019.07.004. Epub 2019 Jul 16.

PMID:
31515017
4.

Is Concurrent Chemotherapy With Radiotherapy for Esophageal Cancer Beneficial in Patients Aged 80 Years or Older?

Jingu K, Takahashi N, Murakami Y, Ishikawa K, Itasaka S, Takahashi T, Isohashi F, Sakayauchi T, Ogawa K; JROSG Working Subgroup of Gastrointestinal Cancers.

Anticancer Res. 2019 Aug;39(8):4279-4283. doi: 10.21873/anticanres.13592.

PMID:
31366518
5.

Variations of the Dose Distribution Between CT- and CBCT-based Plans for Oropharyngeal Cancer.

Otsuka M, Monzen H, Ishikawa K, Doi H, Matsumoto K, Tamura M, Nishimura Y.

In Vivo. 2019 Jul-Aug;33(4):1271-1277. doi: 10.21873/invivo.11599.

6.

Comparing the 7th and 8th editions of the American Joint Committee on Cancer/Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma treated by definitive radiotherapy.

Inada M, Nishimura Y, Ishikawa K, Nakamatsu K, Wada Y, Uehara T, Fukuda K, Anami S, Doi H, Kanamori S.

Esophagus. 2019 Oct;16(4):371-376. doi: 10.1007/s10388-019-00675-y. Epub 2019 May 20.

PMID:
31111308
7.

Neutrophil-to-Lymphocyte Ratio Predicts Survival After Whole-brain Radiotherapy in Non-small Cell Lung Cancer.

Doi H, Nakamatsu K, Anami S, Fukuda K, Inada M, Tatebe H, Ishikawa K, Kanamori S, Monzen H, Nishimura Y.

In Vivo. 2019 Jan-Feb;33(1):195-201. doi: 10.21873/invivo.11459.

8.

Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy.

Anami S, Doi H, Nakamatsu K, Uehara T, Wada Y, Fukuda K, Inada M, Ishikawa K, Kanamori S, Nishimura Y.

J Radiat Res. 2019 Mar 1;60(2):257-263. doi: 10.1093/jrr/rry107.

9.

Antimicrobial agent isolated from Coptidis rhizome extract incubated with Rhodococcus sp. strain BD7100.

Ishikawa K, Takahashi K, Hosoi S, Takeda H, Yoshida H, Wakana D, Tsubuki M, Sato F, Tojo M, Hosoe T.

J Antibiot (Tokyo). 2019 Feb;72(2):71-78. doi: 10.1038/s41429-018-0114-3. Epub 2018 Nov 9.

PMID:
30410008
10.

Mechanical performance of a commercial knowledge-based VMAT planning for prostate cancer.

Tamura M, Monzen H, Matsumoto K, Kubo K, Otsuka M, Inada M, Doi H, Ishikawa K, Nakamatsu K, Sumida I, Mizuno H, Yoon DK, Nishimura Y.

Radiat Oncol. 2018 Aug 31;13(1):163. doi: 10.1186/s13014-018-1114-y.

11.

Definitive chemoradiotherapy for anal canal cancer: single-center experience.

Tachibana I, Nishimura Y, Inada M, Fukuda K, Ishikawa K, Nishikawa T, Yokokawa M, Nakamatsu K, Kanamori S, Hida JI.

Int J Clin Oncol. 2018 Dec;23(6):1121-1126. doi: 10.1007/s10147-018-1316-1. Epub 2018 Jul 10.

PMID:
29992389
12.

Tumor Hypoxia Detected by 18F-fluoromisonidazole Positron Emission Tomography (FMISO PET) as a Prognostic Indicator of Radiotherapy (RT).

Tachibana I, Nishimura Y, Hanaoka K, Inada M, Fukuda K, Tatebe H, Ishikawa K, Nakamatsu K, Kanamori S, Hosono M.

Anticancer Res. 2018 Mar;38(3):1775-1781.

PMID:
29491116
13.

Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.

Tatebe H, Doi H, Ishikawa K, Kawakami H, Yokokawa M, Nakamatsu K, Kanamori S, Shibata T, Kitano M, Nishimura Y.

Anticancer Res. 2018 Feb;38(2):979-986.

PMID:
29374730
14.

Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer.

Ueda H, Takeda M, Ueda S, Kawakami H, Okuno T, Takegawa N, Hayashi H, Tsurutani J, Tamura T, Ishikawa K, Nishimura Y, Nakagawa K.

Oncotarget. 2017 May 17;8(46):80286-80294. doi: 10.18632/oncotarget.17925. eCollection 2017 Oct 6.

15.

A new cinnamoylphenethylamine derivative from a Mongolian Allium species, Allium carolinianum.

Tsuruoka T, Ishikawa K, Hosoe T, Davaajab D, Duvjir S, Surenjav U.

J Nat Med. 2018 Jan;72(1):332-334. doi: 10.1007/s11418-017-1142-1. Epub 2017 Oct 23.

PMID:
29063363
16.

Common origin of methylenedioxy ring degradation and demethylation in bacteria.

Takeda H, Ishikawa K, Yoshida H, Kasai D, Wakana D, Fukuda M, Sato F, Hosoe T.

Sci Rep. 2017 Aug 7;7(1):7422. doi: 10.1038/s41598-017-07370-x.

17.

Septal membrane localization by C-terminal amphipathic α-helices of MinD in Bacillus subtilis mutant cells lacking MinJ or DivIVA.

Ishikawa K, Matsuoka S, Hara H, Matsumoto K.

Genes Genet Syst. 2017 Oct 18;92(2):81-98. doi: 10.1266/ggs.16-00054. Epub 2017 Jun 30.

18.

Asnovolins A-G, Spiromeroterpenoids Isolated from the Fungus Aspergillus novofumigatus, and Suppression of Fibronectin Expression by Asnovolin E.

Ishikawa K, Sato F, Itabashi T, Wachi H, Takeda H, Wakana D, Yaguchi T, Kawai K, Hosoe T.

J Nat Prod. 2016 Sep 23;79(9):2167-74. doi: 10.1021/acs.jnatprod.6b00013. Epub 2016 Sep 14.

PMID:
27626956
19.

Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers.

Matsuura T, Nishimura Y, Nakamatsu K, Kanamori S, Ishikawa K, Tachibana I, Hosono M, Shibata T.

Int J Clin Oncol. 2017 Feb;22(1):52-58. doi: 10.1007/s10147-016-1034-5. Epub 2016 Sep 7.

PMID:
27604973
20.

Isolation and identification of berberine and berberrubine metabolites by berberine-utilizing bacterium Rhodococcus sp. strain BD7100.

Ishikawa K, Takeda H, Wakana D, Sato F, Hosoe T.

Biosci Biotechnol Biochem. 2016 May;80(5):856-62. doi: 10.1080/09168451.2015.1136878. Epub 2016 Feb 16.

PMID:
26882131

Supplemental Content

Loading ...
Support Center